Intellia Therapeutics, Inc. (LON:0JBU)
London flag London · Delayed Price · Currency is GBP · Price in USD
8.10
-0.49 (-5.66%)
At close: May 13, 2025

Intellia Therapeutics Market Cap

Intellia Therapeutics has a market cap or net worth of 664.04 million as of May 16, 2025. Its market cap has decreased by -59.70% in one year.

Market Cap
664.04M
Enterprise Value
220.69M
Revenue
35.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.10

Market Cap Chart

Since May 6, 2016, Intellia Therapeutics's market cap has increased from 537.16M to 664.04M, an increase of 23.62%. That is a compound annual growth rate of 2.38%.

History

DateMarket Cap% Change
May 15, 2025629.83M-33.60%
Dec 31, 2024948.58M-55.75%
Dec 29, 20232.14B-13.15%
Dec 30, 20222.47B-62.02%
Dec 31, 20216.50B152.49%
Dec 31, 20202.57B375.35%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 157.27B
GSK plc 55.33B
Haleon 36.19B
Smith & Nephew 9.46B
ConvaTec Group 5.55B
Hikma Pharmaceuticals 4.59B
HUTCHMED (China) 1.73B
Genus 1.36B
Market Cap Rankings